Patents by Inventor Eivind Per Thor

Eivind Per Thor has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Survivin-derived peptides and uses thereof
    Patent number: 9534030
    Abstract: MHC Class I-restricted peptides derived from the tumor associated antigen, survivin, which peptides are capable of binding to Class I HLA molecules at a high affinity, capable of eliciting INF-?-producing cells in a PBL population of a cancer patient and capable of in situ detection of cytotoxic T cells in a tumor tissue, therapeutic and diagnostic composition comprising the peptide and uses thereof.
    Type: Grant
    Filed: September 28, 2012
    Date of Patent: January 3, 2017
    Assignee: SURVAC APS
    Inventors: Eivind Per Thor Straten, Mads Hald Andersen
  • Survivin-derived peptides and use thereof
    Patent number: 7892559
    Abstract: MHC Class I-restricted peptides derived from the tumor associated antigen, survivin, which peptides are capable of binding to Class I HLA molecules at a high affinity, capable of eliciting INF-?-producing cells in a PBL population of a cancer patient and capable of in situ detection of cytotoxic T cells in a tumor tissue, therapeutic and diagnostic composition comprising the peptide and uses hereof.
    Type: Grant
    Filed: November 19, 2003
    Date of Patent: February 22, 2011
    Assignee: Survac APS
    Inventors: Eivind Per Thor Straten, Mads Hald Andersen
  • Survivin-derived peptides and use thereof
    Publication number: 20070148184
    Abstract: MHC Class I-restricted peptides derived from the tumor associated antigen, survivin, which peptides are capable of binding to Class I HLA molecules at a high affinity, capable of eliciting INF-?-producing cells in a PBL population of a cancer patient and capable of in situ detection of cytotoxic T cells in a tumor tissue, therapeutic and diagnostic composition comprising the peptide and uses thereof.
    Type: Application
    Filed: January 30, 2004
    Publication date: June 28, 2007
    Inventors: Eivind Per Thor Straten, Mads Hald Andersen
  • Survivin-derived peptides and use thereof
    Publication number: 20040210035
    Abstract: MHC Class I-restricted peptides derived from the tumor associated antigen, survivin, which peptides are capable of binding to Class I HLA molecules at a high affinity, capable of eliciting INF-&ggr;-producing cells in a PBL population of a cancer patient and capable of in situ detection of cytotoxic T cells in a tumor tissue, therapeutic and diagnostic composition comprising the peptide and uses hereof.
    Type: Application
    Filed: January 30, 2003
    Publication date: October 21, 2004
    Inventors: Eivind Per Thor Straten, Mads Hald Andersen
  • Survivin-derived peptides and use thereof
    Publication number: 20040176573
    Abstract: MHC Class I-restricted peptides derived from the tumor associated antigen, survivin, which peptides are capable of binding to Class I HLA molecules at a high affinity, capable of eliciting INF-&ggr;-producing cells in a PBL population of a cancer patient and capable of in situ detection of cytotoxic T cells in a tumor tissue, therapeutic and diagnostic composition comprising the peptide and uses hereof.
    Type: Application
    Filed: November 19, 2003
    Publication date: September 9, 2004
    Applicant: BioVision A/S
    Inventors: Eivind Per Thor, Mads Hald
  • Survivin-derived peptides and uses thereof
    Patent number: RE48522
    Abstract: MHC Class I-restricted peptides derived from the tumor associated antigen, survivin, which peptides are capable of binding to Class I HLA molecules at a high affinity, capable of eliciting INF-?-producing cells in a PBL population of a cancer patient and capable of in situ detection of cytotoxic T cells in a tumor tissue, therapeutic and diagnostic composition comprising the peptide and uses thereof.
    Type: Grant
    Filed: July 19, 2018
    Date of Patent: April 20, 2021
    Assignee: SURVAC APS
    Inventors: Eivind Per Thor Straten, Mads Hald Andersen